The upregulated DEGs were mainly enriched in the P53 signaling pathway, PI3K–Akt signaling pathway, proteoglycans in cancer, focal adhesion, and cell cycle; downregulated DEGs were mainly enriched in the modulation of chemical synaptic transmission, regulation of trans-synaptic signaling, and regulation of membrane potential. This evidence concerns the gene TP53 and cancer.